Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?

@article{Grewal2003UnrelatedDH,
  title={Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?},
  author={Satkiran S. Grewal and Juliet N. Barker and Stella M. Davies and John E Wagner},
  journal={Blood},
  year={2003},
  volume={101 11},
  pages={
          4233-44
        }
}
Hematopoietic cell transplantation (HCT) can be curative for selected malignant and nonmalignant diseases.[1][1], [2][2], [3][3], [4][4], [5][5], [6][6], [7][7], [8][8], [9][9], [10][10], [11][11], [12][12], [13][13] However, utilization and success of HCT are limited by several obstacles, primarily 

Tables from this paper

Principles and overview of allogeneic hematopoietic stem cell transplantation.

TLDR
Allogeneic HSCT has become a standard treatment option for a variety of hematologic malignancies and is astandard treatment for many immunodeficiency states, metabolic disorders, and defective hematopoietic states (e.g., Hurler’s syndrome, severe aplastic anemia, thalassemia).

Cord blood transplantation for adult patients with hematological malignancies.

TLDR
It is considered that graft CD34+ cell dose besides nucleated cell dose is important for engraftment and adult patients without suitable related or unrelated bone marrow donors should be considered as candidates for CBT by the choice of CB including both sufficient nucleatedcell dose and CD34- cell dose.

Hematopoietic stem cell transplantation

TLDR
The biology of stem cells, clinical efficacy of HSCT, transplantation procedures, and potential complications are reviewed.

Cord blood transplantation for adults

TLDR
The current state of the art on cord blood transplantation for adults is reviewed, and some of the newer strategies being pursued in order to improve its safety and efficacy are discussed.

Cord-blood transplantation in patients with leukemia--a real alternative for adults.

  • M. Sanz
  • Medicine
    The New England journal of medicine
  • 2004
A steady stream of advances in allogeneic hematopoietic stem-cell transplantation has not only improved the clinical outcome in a variety of malignant and nonmalignant diseases but also widened the

Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children.

  • V. BarlogisLaurence Glasman G. Michel
  • Medicine, Biology
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2011

Hematopoietic Stem Cell Transplantation: History and Perioperative Care of Patients Undergoing HSCT

TLDR
Both the underlying disease process and the complications of HSCT such as graft versus host disease must be taken into consideration when managing Patients who undergo bone marrow transplantation.

Double umbilical cord blood transplantation.

Adult umbilical cord blood transplantation: a comprehensive review

TLDR
Factors leading to the choice of the ‘best available donor’ and ‘ best available unit’ in the case of UCB transplantation are reviewed, with a particular emphasis on confounding factors that impact interpretation.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

  • Priya KumarT. DeFor L. Burns
  • Medicine, Biology
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2008
...

References

SHOWING 1-10 OF 173 REFERENCES

Hematopoietic stem-cell transplants using umbilical-cord blood.

  • E. Gluckman
  • Medicine, Biology
    The New England journal of medicine
  • 2001
Transplantation of umbilical-cord blood was successfully performed for the first time in 1988 to treat a boy with Fanconi's anemia; the donor, the boy's newborn sister, was a perfect HLA match for

Unrelated donor bone marrow transplantation for children with acute leukemia.

  • S. DaviesJ. Wagner N. Ramsay
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1997
TLDR
URD BMT is an effective treatment for children with poor-prognosis acute leukemia and should be considered for all high-risk patients and early referral of patients is strongly recommended.

Stored placental blood for unrelated bone marrow reconstitution.

TLDR
The issues confronting the establishment of a panel of HLA-typed and fully tested placental blood units and the evaluation of their efficacy in transplantation are examined, contrasted with the registry system of volunteer potential donors.

Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children – a Eurocord analysis

TLDR
In children with sustained myeloid engraftment the concern that lymphocyte recovery after CBT could be delayed does not appear to be substantiated by the results.

Placental-blood banking--a new frontier in transfusion medicine.

TLDR
For bone marrow transplantation to succeed, it is crucial to find a donor whose HLA types match those of the recipient, and most bone marrow–transplantation centers try to find one by searching a list of more than 2 million volunteers registered with the National Marrow Donor Program.

Bone marrow transplantation for acute lymphocytic leukemia (ALL).

TLDR
Consideration of speedy availability, transplant-associated toxicity, and antileukemic efficacy of these varying options all need to be balanced for effective clinical decisions on transplant treatment in patients with ALL.

Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution.

"Transplants" of placental blood from siblings have been successful in the reconstitution of ablated bone marrow. We are currently evaluating the feasibility of applying this source of hematopoietic

Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children.

TLDR
The data suggest that CBT recipients can experience a slight delay in hematological recovery when compared with patients given BMT, and the reconstitution of erythropoiesis seems to recapitulate the ontogenetic pattern and the kinetics of recovery of the immune system reproduce that observed after BMT with the peculiarity of B cell expansion in peripheral blood.

Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation.

TLDR
This series of 30 UCB transplants suggests that although CD8 cell recovery is delayed, the pattern of immune reconstitution with UCB is similar to that reported for other stem cell sources.
...